RITUXAN SC
Google image searchProduct monograph
Active ingredient
rituximab, 1600 MG/13.4 ML
DIN: 02473976
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: SINGLE DOSE VIAL - 120 MG/ML
Schedule: Prescription / Schedule D
Company: HOFFMANN-LA ROCHE LIMITED
Date: 24-APR-2018
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
- L01FA — CD20 (Clusters of Differentiation 20) inhibitors (ATC, ATC/DDD)
- L01FA01 — RITUXIMAB (ATC/DDD)
Reference brand drug: Rituxan, Riximyo, Ruxience, Truxima
External Links for Rituxan Sc
Search on Google
Hoffmann-La Roche Limited
Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find rituxan sc photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.